Abstract
BACKGROUND: There is an increasingly diverse range of mobile apps and digital health devices available to help patients manage their health. Despite evidence for the effectiveness of such technologies, their potential has not been fully realized because adoption remains low. Such limited uptake can have direct implications for the intended benefits of these technologies. OBJECTIVE: This study aimed to understand what matters most to US military veterans when deciding whether to use digital health technologies (DHTs) such as mobile health apps or devices to manage their health and compare these factors between veterans with and without prevalent chronic physical and mental health conditions. METHODS: We conducted a cross-sectional analysis of survey data collected from a national sample of veterans who receive care from the Veterans Health Administration (VHA), which was predominantly gathered as part of the last wave of a larger longitudinal data collection effort. RESULTS: Among respondents (n=857), 86.7% (736/849) reported currently using or having previously used ≥1 devices to manage their health, and 78.4% (639/815) also reported using either VHA or non-VHA health apps. Considerations most frequently endorsed as "very important" by veterans when deciding whether to use DHTs included receiving secure messages from their health care team about DHTs, knowing data from DHTs would be used to inform their care, and receiving recommendations from providers to use DHTs. Conversely, considerations most frequently endorsed as "not at all important" included seeing information about DHTs on social media, having community support to use DHTs, and receiving encouragement from peers to use DHTs. Considerations did not significantly differ between veterans with or without prevalent chronic health conditions; however, a greater proportion of veterans with prevalent mental health conditions reported the following considerations to be "very important:" seeing information about DHTs on social media, having community support to use DHTs, having other veterans encourage DHT use, and having help from family, friends, or other important people to use DHTs. CONCLUSIONS: Understanding what matters most to patients when they are deciding to adopt a technology for their health can, and should, inform implementation strategies and other approaches to enhance health-related technology use. Our results suggest that, for veterans, recommendations from health care team members and knowing that the data from DHTs will be used in clinical care are more important than information from social media, community sources, or peers when deciding to use DHTs, although perceptions of importance regarding the latter may differ among patients with different conditions. Our findings suggest that communication from health care team members to patients, perhaps either in-person or electronically, could help encourage DHT adoption and use.